share_log

Positive Week for Biomea Fusion, Inc. (NASDAQ:BMEA) Institutional Investors Who Lost 53% Over the Past Year

Positive Week for Biomea Fusion, Inc. (NASDAQ:BMEA) Institutional Investors Who Lost 53% Over the Past Year

Biomea Fusion, Inc.(納斯達克:BMEA)的機構投資者在過去一年中虧損了53%,但本週表現積極。
Simply Wall St ·  08/24 20:49

Key Insights

主要見解

  • Institutions' substantial holdings in Biomea Fusion implies that they have significant influence over the company's share price
  • A total of 6 investors have a majority stake in the company with 54% ownership
  • Insiders have bought recently
  • 機構在Biomea Fusion的大量持股意味着他們對公司股價有重要影響力。
  • 共有6名投資者持有該公司的大部分股份,擁有54%的所有權。
  • 內部人士最近購買了股票。

A look at the shareholders of Biomea Fusion, Inc. (NASDAQ:BMEA) can tell us which group is most powerful. And the group that holds the biggest piece of the pie are institutions with 51% ownership. Put another way, the group faces the maximum upside potential (or downside risk).

看看Biomea Fusion, Inc. (納斯達克:BMEA)的股東可以告訴我們哪個群體更強大。而持有最大份額的群體是擁有51%所有權的機構。換句話說,這個群體面對着最大的上行潛力(或下行風險)。

After a year of 53% losses, last week's 32% gain would be welcomed by institutional investors as a possible sign that returns might start trending higher.

經歷了一年的53%的虧損,上週32%的增長對機構投資者來說可能是一個好消息,可能意味着回報可能開始上升。

Let's delve deeper into each type of owner of Biomea Fusion, beginning with the chart below.

讓我們深入研究Biomea Fusion的每種所有者,從下面的圖表開始。

1724503740196
NasdaqGS:BMEA Ownership Breakdown August 24th 2024
納斯達克:BMEA所有權分佈2024年8月24日

What Does The Institutional Ownership Tell Us About Biomea Fusion?

機構持股對Biomea Fusion有何影響?

Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.

機構投資者通常將自己的回報與常見的指數回報進行比較。因此,他們通常會考慮購買包括在相關基準指數中的較大公司。

We can see that Biomea Fusion does have institutional investors; and they hold a good portion of the company's stock. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Biomea Fusion, (below). Of course, keep in mind that there are other factors to consider, too.

我們可以看到Biomea Fusion確實有機構投資者,並且他們持有公司的很大一部分股票。這表明在專業投資者中有一些可信度。但是我們不能僅僅依靠這個事實,因爲機構有時也會做出糟糕的投資,就像每個人一樣。如果兩家大型機構投資者同時試圖賣出股票,股價大幅下跌是很常見的。因此,值得檢查Biomea Fusion的過去盈利軌跡(如下所示)。當然,還要考慮其他因素。

1724503741723
NasdaqGS:BMEA Earnings and Revenue Growth August 24th 2024
納斯達克GS:BMEA盈利和營業收入增長2024年8月24日

Since institutional investors own more than half the issued stock, the board will likely have to pay attention to their preferences. It looks like hedge funds own 16% of Biomea Fusion shares. That's interesting, because hedge funds can be quite active and activist. Many look for medium term catalysts that will drive the share price higher. FMR LLC is currently the company's largest shareholder with 15% of shares outstanding. Meanwhile, the second and third largest shareholders, hold 9.9% and 9.7%, of the shares outstanding, respectively. Additionally, the company's CEO Thomas Butler directly holds 6.9% of the total shares outstanding.

由於機構投資者持有超過一半的已發行股份,董事會可能需要注意他們的偏好。看起來對Biomea Fusion股份持有16%的對沖基金。這很有趣,因爲對沖基金可能會非常活躍和激進。許多尋找中期催化劑來推動股價上漲。FMR LLC目前是該公司最大的股東,持有15%的流通股。同時,第二和第三大股東分別持有流通股的9.9%和9.7%。此外,公司CEO Thomas Butler直接持有總流通股的6.9%。

We did some more digging and found that 6 of the top shareholders account for roughly 54% of the register, implying that along with larger shareholders, there are a few smaller shareholders, thereby balancing out each others interests somewhat.

我們進一步調查發現,前6大股東約佔註冊股份的54%,這意味着除了較大的股東外,還有一些較小的股東,從而在一定程度上平衡了彼此的利益。

While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. There are plenty of analysts covering the stock, so it might be worth seeing what they are forecasting, too.

儘管研究公司機構所有權數據是有意義的,但了解分析師的情緒也很有意義,以了解市場的走向。因爲有很多分析師正在跟蹤這個股票,所以看看他們的預測可能是值得的。

Insider Ownership Of Biomea Fusion

Biomea Fusion的內部股權

The definition of an insider can differ slightly between different countries, but members of the board of directors always count. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.

內部人員的定義在不同國家可能會稍有不同,但董事會成員始終算入其中。公司管理負責經營業務,但即使首席執行官是董事會成員,他或她也必須對董事會負責。

I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.

我通常認爲內部人士持股是一件好事。但是,在某些情況下,它會使其他股東更難以對董事會的決定進行問責。

Our most recent data indicates that insiders own a reasonable proportion of Biomea Fusion, Inc.. Insiders have a US$32m stake in this US$249m business. This may suggest that the founders still own a lot of shares. You can click here to see if they have been buying or selling.

根據我們最近的數據顯示,內部人士擁有Biomea Fusion, Inc.相當比例的股份。內部人士在這個2.49億美元的企業中持有3200萬美元的股份。這可能意味着創始人仍然擁有很多股份。您可以點擊這裏查看他們是否一直在買入或賣出。

General Public Ownership

一般大衆所有權

The general public-- including retail investors -- own 11% stake in the company, and hence can't easily be ignored. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.

一般公衆——包括零售投資者——在公司中擁有11%的股份,因此不容易被忽略。雖然持股規模相當大,但如果決策與其他大股東不同步,這可能不足以改變公司政策。

Private Company Ownership

私有公司的所有權

Our data indicates that Private Companies hold 9.7%, of the company's shares. It's hard to draw any conclusions from this fact alone, so its worth looking into who owns those private companies. Sometimes insiders or other related parties have an interest in shares in a public company through a separate private company.

我們的數據顯示,私人公司持有該公司9.7%的股份。僅僅憑此事實很難得出任何結論,因此值得進一步調查誰擁有這些私人公司。有時內部人員或其他相關方可能通過單獨的私人公司持有公共公司的股份。

Next Steps:

下一步:

While it is well worth considering the different groups that own a company, there are other factors that are even more important. Consider for instance, the ever-present spectre of investment risk. We've identified 4 warning signs with Biomea Fusion (at least 3 which are significant) , and understanding them should be part of your investment process.

雖然考慮擁有公司的不同團體是值得的,但還有更重要的因素。例如,要考慮投資風險的不斷潛在。我們已經確定了Biomea Fusion的4個警示信號(其中至少3個是顯著的),了解它們應該是您投資過程的一部分。

But ultimately it is the future, not the past, that will determine how well the owners of this business will do. Therefore we think it advisable to take a look at this free report showing whether analysts are predicting a brighter future.

但最終,決定該業務所有者將獲得多大利益的是未來而非過去。因此,我們認爲最好查看此免費報告,以了解分析師是否預測更光明的未來。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注:本文中的數據是使用最後一個財務報表日期結束的爲期12個月的數據計算的。這可能與全年年度報告數據不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論